About this Journal Submit a Manuscript Table of Contents
Advances in Urology
Volume 2012 (2012), Article ID 181987, 13 pages
Review Article

Bladder Cancer Immunotherapy: BCG and Beyond

Department of Urology, University of Iowa, 375 Newton Road, 3204 MERF, Iowa City, IA 52242, USA

Received 16 March 2012; Accepted 11 May 2012

Academic Editor: Trinity J. Bivalacqua

Copyright © 2012 Eric J. Askeland et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [10 citations]

The following is the list of published articles that have cited the current article.

  • Gopitkumar Shah, Guangjian Zhang, Fanghong Chen, YanLi Cao, Balaraman Kalyanaraman, and William See, “Loss of Bacillus Calmette-Guérin Viability Adversely Affects the Direct Response of Urothelial Carcinoma Cells to Bacillus Calmette-Guérin Exposure,” The Journal of Urology, 2013. View at Publisher · View at Google Scholar
  • Scott Palmer, Sergei G. Sokolovski, Edik Rafailov, and Ghulam Nabi, “Technologic Developments in the Field of Photonics for the Detection of Urinary Bladder Cancer,” Clinical Genitourinary Cancer, 2013. View at Publisher · View at Google Scholar
  • Luís Lima, Daniela Oliveira, Ana Tavares, Teresina Amaro, Ricardo Cruz, Maria J. Oliveira, José A. Ferreira, and Lúcio Santos, “The predominance of M2-polarized macrophages in the stroma of low-hypoxic bladder tumors is associated with BCG immunotherapy failure,” Urologic Oncology: Seminars and Original Investigations, 2013. View at Publisher · View at Google Scholar
  • Regina Arantes-Rodrigues, Rosário Pinto-Leite, Lio Fidalgo-Gonçalves, Carlos Palmeira, Lúcio Santos, Aura Colaço, and Paula Oliveira, “Synergistic Effect between Cisplatin and Sunitinib Malate on Human Urinary Bladder-Cancer Cell Lines,” BioMed Research International, vol. 2013, pp. 1–11, 2013. View at Publisher · View at Google Scholar
  • Jose Alexandre Ferreira, Celso A. Reis, Mylene Carrascal, Paulo F. Seuerino, Andreia Almeida, Rui Vitorino, Paula A. Videira, Luis Lima, Sofia Pereira, Lucio Lara Santos, Mariana Silva, Elisabete Fernandes, Ceu Costa, Teresina Amaro, Maria J. Oliveira, Fabio Dall'Olio, and Francisco Amado, “Overexpression of tumour-associated carbohydrate antigen sialyl-Tn in advanced bladder tumours,” Molecular Oncology, vol. 7, no. 3, pp. 719–731, 2013. View at Publisher · View at Google Scholar
  • Jessica R. Newman, Lisa A. Clough, and Fernando Merino, “Mycobacterium bovis Osteomyelitis of the Thoracic Spine Mimicking a Metastatic Lytic Lesion in a Patient Exposed to Intravesicular Bacille Calmette-Guérin Treatment,” Urology Case Reports, vol. 2, no. 4, pp. 142–144, 2014. View at Publisher · View at Google Scholar
  • Xiaoxuan Liu, Alexander C Dowell, Prashant Patel, Richard P Viney, Michael C Foster, Emilio Porfiri, Nicholas D James, and Richard T Bryan, “Cytokines as effectors and predictors of responses in the treatment of bladder cancer by bacillus Calmette–Guérin,” Future Oncology, vol. 10, no. 8, pp. 1443–1456, 2014. View at Publisher · View at Google Scholar
  • Ronald Rooke, “Can Calcium Signaling be harnessed for cancer immunotherapy?,” Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2014. View at Publisher · View at Google Scholar
  • Linda C Sandin, Thomas H Tötterman, and Sara M Mangsbo, “Local immunotherapy based on agonistic CD40 antibodies effectively inhibits experimental bladder cancer,” OncoImmunology, vol. 3, no. 1, pp. e27400, 2014. View at Publisher · View at Google Scholar
  • Naim B. Farah, Rami Ghanem, and Mahmoud Amr, “Treatment efficacy and tolerability of intravesical Bacillus Calmette-Guerin (BCG) - RIVM strain: induction and maintenance protocol in high grade and recurrent low grade non-muscle invasive bladder cancer (NMIBC),” Bmc Urology, vol. 14, 2014. View at Publisher · View at Google Scholar